This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Seitaro Mizukami: Innovator in Microcapsule Technology
Introduction
Seitaro Mizukami is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of microcapsule technology, particularly through his innovative methods for producing microcapsule powder. His work is recognized for its potential applications in various industries, including pharmaceuticals.
Latest Patents
Mizukami holds a patent for a "Method for producing microcapsule powder." This method involves a concentration step where an aqueous dispersion of microcapsules is supplied into a cyclone for concentration. The process includes both an aqueous dispersion-supplying step and a concentrated dispersion-recovering step. In the supplying step, the dispersion is introduced into a cylindrical member inlet, while the recovery step involves discharging the concentrated microcapsule dispersion through a conical member outlet. He has 1 patent to his name.
Career Highlights
Seitaro Mizukami is currently associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His role at Takeda allows him to leverage his expertise in microcapsule technology to contribute to the development of innovative pharmaceutical solutions.
Collaborations
Mizukami has worked alongside talented colleagues such as Naoki Choda and Tomomichi Futo. Their collaborative efforts have further advanced the research and development of microencapsulation techniques.
Conclusion
Seitaro Mizukami's contributions to microcapsule technology exemplify the impact of innovative thinking in the pharmaceutical industry. His patented methods are paving the way for advancements in drug delivery systems and other applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
